Literature DB >> 9804379

Transgenic mice in the study of polyglutamine repeat expansion diseases.

G P Bates1, L Mangiarini, S W Davies.   

Abstract

An increasing number of neurodegenerative diseases, including Huntington's disease (HD), have been found to be caused by a CAG/polyglutamine expansion. We have generated a mouse model of HD by the introduction of exon 1 of the human HD gene carrying highly expanded CAG repeats into the mouse germ line. These mice develop a progressive neurological phenotype. Neuronal intranuclear inclusions (NII) that are immunoreactive for huntingtin and ubiquitin have been found in the brains of symptomatic mice. In vitro analysis indicates that the inclusions are formed through self aggregation via the polyglutamine repeat into amyloid-like fibrils composed of a cross beta-sheet structure that has been termed a polar zipper. Analysis of patient material and other transgenic lines has now shown NII to be a common feature of all of these diseases. In the transgenic models, inclusions are present prior to the onset of symptoms suggesting a causal relationship. In contrast, neurodegeneration occurs after the onset of the phenotype indicating that the symptoms are caused by a neuronal dysfunction rather than a primary cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804379     DOI: 10.1111/j.1750-3639.1998.tb00196.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  14 in total

Review 1.  Transgenic models of Huntington's disease.

Authors:  K Sathasivam; C Hobbs; L Mangiarini; A Mahal; M Turmaine; P Doherty; S W Davies; G P Bates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila.

Authors:  Barbara L Apostol; Alexsey Kazantsev; Simona Raffioni; Katalin Illes; Judit Pallos; Laszlo Bodai; Natalia Slepko; James E Bear; Frank B Gertler; Steven Hersch; David E Housman; J Lawrence Marsh; Leslie Michels Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

3.  CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.

Authors:  Margarita Arango; Sébastien Holbert; Dania Zala; Emmanuel Brouillet; James Pearson; Etienne Régulier; Ashwani Kumar Thakur; Patrick Aebischer; Ronald Wetzel; Nicole Déglon; Christian Néri
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

4.  Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.

Authors:  Michael J Mihm; Deborah M Amann; Brandon L Schanbacher; Ruth A Altschuld; John Anthony Bauer; Kari R Hoyt
Journal:  Neurobiol Dis       Date:  2006-11-27       Impact factor: 5.996

5.  Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.

Authors:  Delphine Charvin; Peter Vanhoutte; Christiane Pagès; Emilliana Borrelli; Emiliana Borelli; Jocelyne Caboche
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

6.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

7.  Monkey hybrid stem cells develop cellular features of Huntington's disease.

Authors:  Chuti Laowtammathron; Eric Ch Cheng; Pei-Hsun Cheng; Brooke R Snyder; Shang-Hsun Yang; Zach Johnson; Chanchao Lorthongpanich; Hung-Chih Kuo; Rangsun Parnpai; Anthony W S Chan
Journal:  BMC Cell Biol       Date:  2010-02-05       Impact factor: 4.241

8.  Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Nicholas B Miliaras; Alex Kazantsev; Yury O Chernoff; J Michael McCaffery; Beverly Wendland; Michael Y Sherman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 9.  Making yeast tremble: yeast models as tools to study neurodegenerative disorders.

Authors:  Michael Y Sherman; Paul J Muchowski
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

10.  Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease.

Authors:  Kittiphong Putkhao; Jannet Kocerha; In-Ki Cho; Jinjing Yang; Rangsun Parnpai; Anthony W S Chan
Journal:  Stem Cells Dev       Date:  2013-01-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.